Expanding access to novel and emerging radioprecursors for research and clinical innovation in Nuclear Medicine.
At Clionix, we continuously monitor global advancements in Nuclear Medicine to identify and support access to innovative radioprecursors that enable the next generation of diagnostic and therapeutic applications.
Our team actively collaborates with international suppliers and research partners to source, produce, and deliver specialized radionuclides and radiochemical precursors tailored to emerging radiopharmaceutical development.
Whether for preclinical research, clinical trials, or custom formulation, Clionix helps institutions access hard-to-find or novel isotopes needed for cutting-edge radiopharmaceutical studies.
| Specification | Details |
|---|---|
| Product Type | Various novel radioprecursors |
| Availability | Upon request |
| Application Areas | Research, preclinical studies, early-phase clinical trials |
| Quality Control | Supplied with full analytical and radiochemical certification |
| Certification | GMP or research-grade (depending on isotope and supplier) |
| Customization | Formulation and activity level available upon request |
| Support | Sourcing assistance and regulatory guidance |